Page last updated: 2024-08-26

2,3-bis(4-hydroxyphenyl)-propionitrile and Multiple Sclerosis

2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Multiple Sclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crawford, DK; Kumar, S; Mangiardi, M; Moore, S; Patel, R; Suwanna, N; Tiwari-Woodruff, SK1
Itoh, N; Khalaj, AJ; Kumar, S; Martinez-Torres, L; Moore, SM; Nakai, J; Tiwari-Woodruff, SK; Winchester, Z; Yoo, T; Yoon, J1

Other Studies

2 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Multiple Sclerosis

ArticleYear
Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
    Neurobiology of disease, 2013, Volume: 56

    Topics: Animals; Blotting, Western; Brain-Derived Neurotrophic Factor; Calpain; Caspase 3; Corpus Callosum; Electrophysiological Phenomena; Encephalomyelitis, Autoimmune, Experimental; Estrogen Receptor beta; Female; Immunohistochemistry; Ligands; Male; Mice; Mice, Inbred C57BL; Microscopy, Electron; Multiple Sclerosis; Myelin Sheath; Nitriles; Oligodendroglia; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Postural Balance; Selective Estrogen Receptor Modulators; Signal Transduction; Spinal Cord; TOR Serine-Threonine Kinases

2013
Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand.
    Proceedings of the National Academy of Sciences of the United States of America, 2013, Nov-19, Volume: 110, Issue:47

    Topics: Animals; Cell Lineage; Estrogen Receptor beta; Immunohistochemistry; Mice; Mice, Knockout; Microscopy, Electron; Microscopy, Fluorescence; Multiple Sclerosis; Myelin Sheath; Nitriles; Oligodendroglia; Propionates; Spinal Cord

2013